China’s humanoid robot IPO slowdown no threat to firms with ‘genuine strength’: Deloitte
Beijing’s recent tightening of approvals for humanoid robot makers seeking initial public offerings (IPOs) poses no threat to companies with clear commercialisation strategies, as funding channels remain wide open for qualified players, according to Deloitte China. “Market funds are shifting from the ‘blind rush’ of the past to ‘fine screening’,” said Dick Kay, Deloitte China’s capital market…
Deloitte China reported on Beijing’s recent tightening of approvals for humanoid robot companies seeking initial public offerings (IPOs) and its potential impact on the market. Despite stricter regulations, companies with a clear commercialization strategy and sustainable revenue growth remain eligible for capital market financing, according to Dick Kay, Deloitte China’s national leader for capital market services.
Investors and regulators are now focusing on the long-term viability of these companies, rather than just the initial hype surrounding the sector. This shift came after a significant decline in Unitree Robotics' share price following its IPO, with the company's value plummeting by over US$30 billion within a month. Despite the regulatory changes, Deloitte predicts a record high of HK$480 billion in IPO fundraising for Hong Kong in 2026, a 60 percent increase from the previous year’s estimate.
The Hong Kong market remains robust, fueled by a strong pipeline of mega listings and policy incentives for dual mainland and Hong Kong listings. However, investors should remain vigilant for potential volatility due to US interest rate hikes and unforeseen black swan events.
Written by urgent.news from SCMP Business's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
